Pharmaceutical needs assessmentsU.K.
3.—(1) The statement of the needs for pharmaceutical services which each HWB is required to publish by virtue of section 128A of the 2006 Act M1 (pharmaceutical needs assessments), whether it is the statement of its first assessment or of any revised assessment, is referred to in these Regulations as a “pharmaceutical needs assessment”.
(2) The pharmaceutical services to which each pharmaceutical needs assessment must relate are all the pharmaceutical services that may be provided under arrangements made by [F1NHS England] for—
(a)the provision of pharmaceutical services (including directed services) by a person on a pharmaceutical list;
(b)the provision of local pharmaceutical services under an LPS scheme (but not LP services which are not local pharmaceutical services); or
(c)the dispensing of drugs and appliances by a person on a dispensing doctors list (but not other NHS services that may be provided under arrangements made by [F1NHS England] with a dispensing doctor).
Textual Amendments
F1Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1
Marginal Citations
M1Inserted by the Health Act 2009 (c. 21), section 25.